doi: 10.1001/archinternmed.2011.182.
A quantitative analysis of adverse events and "overwarning" in drug labeling
Affiliations
- PMID: 21606101
- DOI: 10.1001/archinternmed.2011.182
Item in Clipboard
A quantitative analysis of adverse events and "overwarning" in drug labeling
Arch Intern Med.
.
No abstract available
Comment in
-
Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".Arch Intern Med. 2011 May 23;171(10):946-7. doi: 10.1001/archinternmed.2011.200. Arch Intern Med. 2011. PMID: 21606102 No abstract available.
Similar articles
-
Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".Arch Intern Med. 2011 May 23;171(10):946-7. doi: 10.1001/archinternmed.2011.200. Arch Intern Med. 2011. PMID: 21606102 No abstract available.
-
Postmarketing modifications in the safety labeling of the new antiepileptics.Neurology. 2007 May 1;68(18):1536-7. doi: 10.1212/01.wnl.0000260700.58495.f6. Neurology. 2007. PMID: 17470758 No abstract available.
-
Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance.Food Drug Law J. 2007;62(3):529-46. Food Drug Law J. 2007. PMID: 17915395 No abstract available.
-
Improving drug safety monitoring.Indian Pediatr. 2003 Dec;40(12):1167-75. Indian Pediatr. 2003. PMID: 14722367 Review.
-
Improving the reporting of adverse drug reactions in the hospital setting.Postgrad Med. 2010 Nov;122(6):154-64. doi: 10.3810/pgm.2010.11.2233. Postgrad Med. 2010. PMID: 21084792 Review.
Cited by
-
Network Patterns of Herbal Combinations in Traditional Chinese Clinical Prescriptions.Front Pharmacol. 2021 Jan 20;11:590824. doi: 10.3389/fphar.2020.590824. eCollection 2020. Front Pharmacol. 2021. PMID: 33551800 Free PMC article.
-
Exploring Novel Computable Knowledge in Structured Drug Product Labels.AMIA Jt Summits Transl Sci Proc. 2020 May 30;2020:403-412. eCollection 2020. AMIA Jt Summits Transl Sci Proc. 2020. PMID: 32477661 Free PMC article.
-
Discrepancies Between the Labels of Originator and Generic Pharmaceutical Products: Implications for Patient Safety.Drugs Real World Outcomes. 2020 Jun;7(2):131-139. doi: 10.1007/s40801-020-00187-7. Drugs Real World Outcomes. 2020. PMID: 32323200 Free PMC article.
-
Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):434-454. doi: 10.1016/j.bbcan.2019.04.005. Epub 2019 Apr 26. Biochim Biophys Acta Rev Cancer. 2019. PMID: 31034926 Free PMC article. Review.
-
Comparison of the safety information on drug labels in three developed countries: The USA, UK and Canada.Saudi Pharm J. 2017 Dec;25(8):1103-1107. doi: 10.1016/j.jsps.2017.07.006. Epub 2017 Jul 11. Saudi Pharm J. 2017. PMID: 30166896 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
